SCHEMBL632584

SCHEMBL632584

C/C(=C/CC[C@@]1(C)[C@@H]2CC3[C@@H](C2)C31C)CO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 1.00
BTN3A1 O00481 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29825529 1.00 CNR2 (1.00) CNR2BTN3A1
SCHEMBL29825534 1.00 CNR2 (1.00) CNR2BTN3A1
SCHEMBL15711544 1.00 CNR2 (1.00) CNR2BTN3A1
SCHEMBL300787 1.00 CNR2 (1.00) CNR2BTN3A1
SCHEMBL6515127 1.00 CNR2 (1.00) CNR2BTN3A1
SCHEMBL23576230 1.00 CNR2 (1.00) CNR2BTN3A1
SCHEMBL632585 1.00 CNR2 (1.00) CNR2BTN3A1
SCHEMBL15711510 1.00 CNR2 (1.00) CNR2BTN3A1
SCHEMBL22372699 1.00 CNR2 (1.00) CNR2BTN3A1
SCHEMBL29349993 1.00 CNR2 (1.00) CNR2BTN3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 688 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4637702-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF Coty Inc. (US) 2025-10-29 EP claimed
WO-2024137340-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF COTY INC. (US) 2024-06-27 WO claimed
US-20230380428-A1 BIODEGRADABLE CLEANING PRODUCTS, METHODS OF PRODUCTION, AND THEIR COMPOSITIONS SUSTAINABLE COMMUNITY DEV LLC (US) 2023-11-30 US claimed
EP-4257663-A1 FOOD CONTACT SURFACE SANITIZING LIQUID The Procter & Gamble Company (US) 2023-10-11 EP claimed
US-20220056485-A1 METHOD FOR PRODUCING FRAGRANT ALCOHOLS FIRMENICH SA (CH) 2022-02-24 US claimed
US-11002716-B2 Method of resolving defined known or suspected allergens in a complex mixture of perfume ingredients, and compositions GIVAUDAN SA (CH) 2021-05-11 US claimed
EP-3465198-B1 METHOD OF RESOLVING ALLERGENS IN PERFUME INGREDIENTS GIVAUDAN SA (CH) 2020-08-19 EP claimed
US-20200172936-A1 METHOD FOR PRODUCING FRAGRANT ALCOHOLS FIRMENICH SA (CH) 2020-06-04 US claimed
US-20200121605-A1 METHODS AND COMPOSITIONS FOR LOCALIZED INTRADUCTAL DRUG DELIVERY TO THE BREAST AND REGIONAL LYMPH NODES SOUTH DAKOTA BOARD OF REGENTS (US) 2020-04-23 US claimed
CN-110292573-A A kind of relieve stagnation sleeping compound essential oil 颇黎芳香医药科技(上海)有限公司 2019-10-01 CN claimed
US-20030166497-A1 Process for making perfume containing surfactant compositions having perfume burst and enhanced perfume deposition when diluted UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-09-04 US claimed
US-20030166498-A1 Process for making perfume containing surfactant compositions having perfume burst when diluted UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-09-04 US claimed
WO-2003072078-A1 PERFUME CONTAINING SURFACTANT COMPOSITIONS HAVING PERFUME BURST WHEN DILUTED AND PROCESS THEREOF UNILEVER PLC (GB) 2003-09-04 WO claimed
CN-1433461-A Fabric care compositions and systems for delivering clean and fresh scent during lipophilic fluid treatment PROCTER & GAMBLE (US) 2003-07-30 CN claimed
CN-1105175-C Fabric softener compositions with reduced environmental impact PROCTER & GAMBLE (US) 2003-04-09 CN claimed
CN-1094517-C Detergent composition containing efficient enduring perfume PROCTER & GAMBLE (US) 2002-11-20 CN claimed
US-20020151600-A1 Autonomic nerve regulating agent KAO CORPORATION (JP) 2002-10-17 US claimed
CN-1169749-A Detergent compositions containing enduring perfume PROCTER & GAMBLE (US) 1998-01-07 CN claimed
CN-1169157-A Fabric softener compositions with reduced environmental impact PROCTER & GAMBLE (US) 1997-12-31 CN claimed
US-3970706-A MULTISTAGE AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) 1976-07-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200121605-A1 METHODS AND COMPOSITIONS FOR LOCALIZED INTRADUCTAL DRUG DELIVERY TO THE BREAST AND REGIONAL LYMPH NODES LDHB, LDHA, LIPA CNR2 4490/4885BTN3A1 1160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.